Evidence map›Paper›PMID 28608804›Full record

Trial reportNutrients2017

Phytosterols and Omega 3 Supplementation Exert Novel Regulatory Effects on Metabolic and Inflammatory Pathways: A Proteomic Study.

Carmen Lambert, Judit Cubedo, Teresa Padró, Joan Sánchez-Hernández, Rosa M Antonijoan, Antonio Perez, Lina Badimon

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Carmen LambertCardiovascular Science Institute-ICCC IIB-Sant Pau, 08025 Barcelona, Spain. clambert@santpau.cat.
Judit CubedoCardiovascular Science Institute-ICCC IIB-Sant Pau, 08025 Barcelona, Spain. clambert@santpau.cat.
Teresa PadróCardiovascular Science Institute-ICCC IIB-Sant Pau, 08025 Barcelona, Spain. jcubedo@csic-iccc.org.
Joan Sánchez-HernándezCiber DEM, 28029 Madrid, Spain. jsanchezh@comb.cat.
Rosa M AntonijoanMedicament ResearchCenter (CIM), Hospital Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain. rantonijoana@santpau.cat.
Antonio PerezEndocrinology Department, Hospital Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain. APerez@santpau.cat.
Lina BadimonCardiovascular Science Institute-ICCC IIB-Sant Pau, 08025 Barcelona, Spain. lbadimon@csic-iccc.org.
Centro de Investigación en Red en Enfermedades Cardiovasculares · ESHospital de Sant Pau · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular disease (CVD) remains one of the major causes of death and disability worldwide. In addition to drug treatment, nutritional interventions or supplementations are becoming a health strategy for CVD prevention. Phytosterols (PhyS) are natural components that have been shown to reduce cholesterol levels; while poly-unsaturated fatty acids (PUFA), mainly omega-3 (ω3) fatty acids, have shown to reduce triglyceride levels. Here we aimed to investigate whether the proteins in the main lipoproteins (low density lipoproteins (LDL) and high density lipoproteins (HDL)) as well as proteins in the lipid free plasma fraction (LPDP) were regulated by the intake of PhyS-milk or ω3-milk, in overweight healthy volunteers by a proteomic based systems biology approach. The study was a longitudinal crossover trial, including thirty-two healthy volunteers with body mass index (BMI) 25-35 kg/m² (Clinical Trial: ISRCTN78753338). Basal samples before any intervention and after 4 weeks of intake of PhyS or ω3-milk were analyzed. Proteomic profiling by two dimensional electrophoresis (2-DE) followed by mass spectrometry-(MALDI/TOF), ELISA, Western blot, conventional biochemical analysis, and in-silico bioinformatics were performed. The intake of PhyS-milk did not induce changes in the lipid associated plasma protein fraction, whereas ω3-milk significantly increased apolipoprotein (Apo)- E LDL content (

Indexed as

AnimalsCross-Over StudiesDietary FatsDouble-Blind MethodFatty Acids, Omega-3FemaleGene Expression RegulationHumansInflammationMaleMiddle AgedMilkPhytosterolsSignal TransductionDietary FatsFatty Acids, Omega-3PhytosterolsHDLinflammationLDLlipid metabolismomega 3phytosterols

Identifiers

PMID28608804
PMCPMC5490578
OpenAlexW2625010390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.